Saturday, February 2, 2013

Prenatal Alcohol and Drug Exposures in Adoption



This is a summary of a 2005 scholarly article examining multiple research reports regarding prenatal alcohol and drug exposure. It was really helpful to us in deciding what situations we are comfortable with, when the time comes.



“Families choosing to adopt domestically or internationally are faced with the possibility of prenatal substance exposure for their child. Alcohol use, drug use, and exposure to environmental agents by pregnant women can be harmful to the developing fetus, with many known short- and long-term effects on organ development, somatic growth, and neurodevelopment. As more families turn to medical providers for consultation before adoption, the challenge of accurately identifying risk factors for poor medical or cognitive outcomes becomes paramount.


Prenatal substance exposure is just one of the important factors in this risk assessment, but it is one that parents frequently have questions about before and after the adoption of their child”.



Alcohol

“Children born to women who drink heavily on a regular basis in the first trimester of pregnancy have the greatest risk of central nervous system damage. The first month of pregnancy is particularly crucial for development of the central nervous system and the midportion of the face. Unfortunately, this early in pregnancy, many women do not realize that they are pregnant and continue their usual pattern of alcohol ingestion”.



“Although there is no convincing evidence to date of a ‘‘safe’’ threshold of prenatal alcohol consumption, one major dysmorphology textbook argues that low birth weight and ‘‘mild’’ disability can be seen at an exposure of roughly 2 alcoholic drinks per day (lower in recent studies). When 4 to 6 drinks are consumed, additional clinical features become evident. Most of the children who are believed to have the full expression of Fetal Alcohol Syndrome are born to women consuming 8 to 10 drinks or more per drinking occasion, on a regular if not daily basis, for at least the first trimester. It is estimated that the risk of a ‘‘serious problem” in the offspring of chronically alcoholic women ranges from 30% to 50%. The greatest risk is that of mental deficiency as well as a host of learning and behavioral disabilities”.



“Manifestations of central nervous system dysfunction may include mental retardation or borderline IQ scores, neuromotor deficits, attentional issues and hyperactivity, and impaired social and adaptive abilities”.



Opiates

“There is no known congenital malformation associated with prenatal opiate exposure. There have been harmful fetal effects described with heroin and methadone use, however, and infants born to addicted women can suffer withdrawal in the newborn period”.



Effects on baby include low birth weight, increased risk of preterm delivery (less so with methadone compared to heroin), withdrawal symptoms (eg, hyperirritability, tremors, convulsions), gastrointestinal distress, respiratory distress, and autonomic disturbances (more severe with methadone because it has a longer half life).



“Recent studies… suggest mild memory and perceptual difficulties in older children [exposed to opiates], but overall test scores are still within the normal range”.



Tobacco

“Prenatal tobacco exposure has consistently been associated with poor fetal growth and is the single most important cause of low birth weight in developed countries. Even environmental smoke exposure has been implicated in low birth weight, fetal death, and preterm delivery. Finally, a growing body of evidence is implicating smoking during pregnancy in a range of adverse behavioral and cognitive outcomes”.



“Nicotine readily crosses the placenta and distributes freely to the central nervous system, having direct and indirect effects on neural development. Intrauterine hypoxia, mediated by carbon monoxide and reduced uterine blood flow, is a major mechanism of the growth impairment linked to prenatal tobacco exposure”.



“Tobacco smoking during pregnancy has been associated with placenta previa, placental abruption, premature rupture of membranes, preterm birth, intrauterine growth restriction, and sudden infant death syndrome (SIDS)”.



“Infants born to mothers who smoke tobacco display higher rates of impaired neurobehavior, with reduced habituation, lower arousal, hypertonicity and tremors, sucking difficulties, worse autonomic regulation, and altered cries”.



Marijuana

“Marijuana use during pregnancy may have a modest effect on prenatal growth, but the results are inconsistent from study to study…These effects, if any, are not associated with later growth deficiency, although a few studies have suggested an impact on height as well as persistent negative effects on head circumference in the offspring of heavy marijuana users. This review found no consistent link between prenatal marijuana exposure and other adverse pregnancy outcomes or congenital malformations”.



“Although prenatal tobacco exposure is associated with deficits in IQ, impulse control, and other fundamental aspects of performance, prenatal marijuana exposure does not impair IQ or basic visuoperception but influences the application of these skills in problem-solving situations requiring visual integration, analysis, and sustained attention. Marijuana is argued to have an impact on higher level executive function and performance in a ‘‘top-down’’ fashion, in contrast to tobacco’s ‘‘bottom-up’’ effects”.



Cocaine

“The use of cocaine in pregnancy has been associated with a number of obstetric complications, such as stillbirth, placental abruption, premature rupture of membranes, fetal distress, and preterm delivery”.



“Prenatal cocaine abuse may cause specific neurobehavioral and learning problems, although it is not associated with global cognitive deficits. Infant neurobehavioral abnormalities like irritability or excitability, sleep difficulties, and state regulation difficulty as well as transient neurologic abnormalities like tremor, hypertonia, and extensor posturing have been reported. Heavy prenatal cocaine use has been linked to poor memory and information processing in infancy. At 3 years of age, increased fussiness, difficult temperament, and behavior problems were described.” 

5/27/13- Current news article: http://chroniclesofanadoption.blogspot.com/2013/05/crack-baby-scare-overblown.html



Meth

“Although the impact of methamphetamine use during human pregnancy is currently unknown, animal studies have demonstrated neurotoxic effects of amphetamines and remodeling of synaptic morphology in response to prenatal methamphetamine exposure. One study did describe a smaller putamen, globus pallidus, and hippocampus in methamphetamine-exposed children”.



“Women using methamphetamine during pregnancy may have an increased rate of premature delivery and placental abruption. Methamphetamine use during pregnancy is linked to fetal growth restriction and, occasionally, withdrawal symptoms requiring pharmacologic intervention at birth. Clefting, cardiac anomalies, and fetal growth reduction have been described in infants exposed to amphetamines during pregnancy”.



“The scant research describing the outcomes of methamphetamine-exposed children describes possible links with aggressive behavior, peer problems, and hyperactivity. A small recent study found that methamphetamine-exposed children scored lower on measures of visual motor integration, attention,verbal memory, and long-term spatial memory. In rats, even low doses of prenatal methamphetamine exposure can alter learning and memory in adulthood”.



Other things to remember

“This review, and most of the research literature, has examined each of these alcohol and drug exposures one by one. In reality, polysubstance exposure is perhaps more common; however, to date, we have little understanding of how these and other prenatal exposures interact with each other to affect the developing fetus”.



“For children of adoption, it is sobering to consider how these substance exposures, in combination with other social and biologic risks, may make affected children more vulnerable to the adverse effects of malnutrition, neglect, abuse, multiple placements, or institutionalization. At a minimum, it seems less likely that early neurobehavioral problems can be repaired in such environments. Conversely, adopted children are typically received into loving and nurturing homes with motivated and resourceful parents. This is a remarkable intervention in and of itself, affording children with multiple vulnerabilities the opportunity for catch-up growth and development, formation of stable and secure attachments, early diagnosis of primary disabilities, appropriate services, and prevention of secondary disabilities. The lifelong impact of this caregiving trajectory on the long-term effects of prenatal alcohol and drug exposures remains to be seen”.






Following a compilation of research regarding other substances not addressed in the above article:



Benzos
“There are many possible risks to the fetus whenever anxiolytic medications are prescribed to pregnant women. The onset of teratogenic effects may be immediate or delayed. Possible effects include abortion, malformation, intrauterine growth retardation, functional deficits, carcinogenesis, and mutagenesis. The risk of malformation is greatest when the fetus is exposed between two and eight weeks after conception. If the drugs are administered at or near term, they may cause fetal dependence and eventual withdrawal symptoms.”

One study found benzo-exposed low birthweight babies caught up at “an early stage”. Gross motor development was behind from 6-10 months but was nearly normal at age 18 months.

Babies exposed to benzos during pregnancy are at risk for low birthweight, breathing difficulties, floppy muscles, unstable body temperature, alteration in heart rate, and withdrawal syndrome (irritability, convulsions, etc).

“Some early studies in animals and humans suggested a slight increase in the risk for cleft lip and/or cleft palate if a benzodiazepine was taken during the first trimester. Since these early reports, there have been studies and reviews that have not supported an association between benzodiazepines and cleft lip or palate or birth defects in general. It is generally felt that exposure to a benzodiazepine does not significantly increase the risk for birth defects”.


Antidepressants


“Tricyclic antidepressants (TCA) are generally considered safe for use during pregnancy (Gilstrap & Little, 1998, Lee et al., 2000). The birth incidence of congenital malformations is not increased nor does there seem to be any alteration of brain anatomy based on human studies. Considering cognitive and behavioural assessments there seem to be no negative effects of prenatal TCA administration.”
Example: amitriptyline

“SRIs are… prescribed and indicated for use in moderate to severe depression during pregnancy (Lee et al., 2000). Several studies have found no increased risk of congenital malformations when using SSRIs during the first trimester (Koren, 2001; Kulin et al., 1998; Nulman et al., 2002). With respect to cognitive development, Nulman et al. (2002)With respect to cognitive development, Nulman et al carried out a prospective controlled study using SSRI exposure throughout pregnancy. They found no increase in delay of cognitive or language development in pre-school or early school aged children. Similarly, Simon et al. (2002) found no increased risk of developmental delay or congenital malformations after SSRI exposure. However, a recent study by Casper et al. (2003) showed a different trend after SSRI exposure. In a well-controlled study, the children of depressed mothers exposed to SSRI or unexposed depressed mothers were followed up to age of 40 months. They found that children prenatally exposed to SSRIs scored lower on the psychomotor indexes of the Bayley Scales of Infant Development test and lower on the motor quality factor of the Bayley Behavioral Rating Scale. The authors suggest that subtle motor developmental delays may be one of the side effects of prenatal SSRI exposure.”
Example: Celexa, Lexapro, Prozac, Paxil, Zoloft